1
answer
0
watching
58
views

Estrogen-dependeant breast cancer therapies (such as raloxifene)are focused on preventing activation of the estrogen responseelement (ERE).

1-Explain how estrodiol (E2) activates the ERE and why thispromotes tumor growth.

2-Identify three different proteins currently targeted by breastcancer drugs, and explain how the protein-drug interaction blocksERE activation in each case.

For unlimited access to Homework Help, a Homework+ subscription is required.

Deanna Hettinger
Deanna HettingerLv2
29 Sep 2019

Unlock all answers

Get 1 free homework help answer.
Already have an account? Log in

Related textbook solutions

Related questions

Weekly leaderboard

Start filling in the gaps now
Log in